Friday, October 24, 2025

Latest

Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market today. The firm’s initial public offering is looking to raise US$69.0 million and is expected to close on March 29, 2022.

The offering consists of 4.6 million common shares, upsized from 4.0 million shares, selling at US$15.00 per share. The company intends to use the proceeds to fund the clinical development and expansion of its drug candidate epetraborole, and for general corporate purposes, including working capital and operating expenses.

Cowen, SVB Leerink, and Evercore ISI act as the joint bookrunners for the said offering. The underwriters were granted a 30-day over-allotment option to purchase additional 690,000 shares at the same IPO price.

The Menlo Park-based biotech company is focused on developing epetraborole, an experimental oral treatment for patients with chronic non-tuberculous mycobacterial lung disease.

LOGO

Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Steadright Enters MOU To Acquire Historic Goundafa Polymetallic Mine In Morocco

Military Seizes Power in Madagascar After President Flees

Related News

Financial SPAC FG Acquisition Announces US$100 Million TSX IPO

Blank check firm FG Acquisition is looking to go public on the Toronto Stock Exchange....

Tuesday, March 22, 2022, 02:18:00 PM

Tampa Bay Rays Owner-Led SPAC Counter Press Acquisition Prices US$75 Million IPO

Special purpose acquisition company Counter Press Acquisition Corp. (Nasdaq: CPAQU) started trading publicly on the...

Thursday, February 10, 2022, 02:21:00 PM

OLX Founder-Led Tech SPAC Global Technology Acquisition Closes US$200.0 Million IPO

Special purpose acquisition company Global Technology Acquisition Corp. I (Nasdaq: GTACU) closed on Monday its...

Tuesday, October 26, 2021, 02:07:00 PM

Language Platform Duolingo Files For IPO On Nasdaq

Language learning platform Duolingo Inc. announced Monday that it has filed a registration statement relating...

Tuesday, June 29, 2021, 10:53:00 AM

Squarepace: The IPO Deep Dive

If you’re a business looking to have an online presence, you might have tried creating...

Tuesday, May 18, 2021, 01:30:00 PM